IP Qualifications
| Qualification |
|---|
| Registered Singapore Patent Attorney |
Academic Qualifications
| Qualification | Institution | Year of Completion |
|---|---|---|
| Graduate Certificate in Intellectual Property Law (Distinction) | National University of Singapore | 2015 |
| Doctor of Philosophy (Science) | University of Sydney, Australia | 2011 |
| Bachelor of Science (Chemistry) (Advanced) (Hons I) | University of Sydney, Australia | 2006 |
Industry Experience
| Position | Organisation/Institution | Date of Tenure |
|---|---|---|
| Postdoctoral Researcher | Northwestern University, USA | 2011 - 2013 |
Selected Patent Cooperation Treaty (PCT) Specifications
| PCT Publication Number | Title of Application |
|---|---|
| PCT/SG2015/050038 | Fused pyrimidine-based hydroxamate derivatives |
| PCT/SG2016/050019 | Fillers for polymers |
| PCT/SG2016/050104 | Composite material for drug delivery |
| PCT/SG2017/050085 | Durable hydrophobic coating composition |
| PCT/SG2017/050198 | A multimodal fluorescent probe |
| PCT/SG2018/050342 | Cell-penetrating glycosaminoglycan mimetics |
| PCT/SG2019/050146 | Thermal control system |
Experience and Technical Background
Experienced in the following areas of patent practice:
- Local & Foreign Prosecution
- Patent Drafting
- Searches/Opinions
- Litigation support
- Validity & Infringement
- Strategic Advice
- Patentability Advice
Primary patent practice areas by technology:
- Materials
- Pharmaceuticals
- Polymers
- Organic chemistry
- Inorganic Chemistry
- Chemical Engineering
Research/industry background:
A. General technical areas:
- Bioinorganic Medicinal Chemistry
- Cell imaging
- Metal complexes
- Peptide chemistry
B. Honours research:
- Investigated the use of cobalt complexes as chaperones for anticancer agents
C. PhD research:
- Investigated the use of cobalt-complexes that release their ligands only in hypoxic environments, for specific delivery of antitumour agents in hypoxic regions of solid tumours. Synthesized the ligands and complexes and tested the hypothesis in cells as well as in vitro tumor models such as spheroids using fluorescence microscopy.
- Investigated the use of peptides that enter cells only in the presence of tumour-specific enzymes for specific delivery of antitumour agents in tumours. Synthesized the peptides and tested the hypothesis in in cells as well as in vitro tumour models using fluorescence microscopy.
D. Industry experience:
- Worked as a postdoctoral fellow at Northwestern University, in a project on cobalt complexes that selectively inhibit proteins such as zinc finger transcription factors, matrix metalloproteinases and metallo-ß-lactamases that contain histidine residues in the active site.